Equity benchmark Sensex surrendered most of the day’s gains to end marginally higher on Monday as investors chose to book profits after a swift market rally. After surging over 640 points in early ... ( read original story ...)
Japan Pharma Stock Surges 60% This Year to Reach Sony’s Size
There’s a new king in the world of Japanese pharma after hopes for a coronavirus treatment helped to turbocharge its shares.Chugai Pharmaceutical Co., Japan’s leading oncology company, is the best ... ( read original story ...)
Tokyo’s Bar Hosts to Get PCR Tests as Japan Tries to Quash Virus
Japan aims to regularly test workers in Tokyo’s sprawling nighttime entertainment district for coronavirus, as host clubs and other adult establishments continue to be blamed for the bulk of the ... ( read original story ...)
Japanese Market Continues Winning Streak
Japanese shares rose for a fifth straight day on Friday. Market heavyweights SoftBank Group and Fast Retailing are higher by more than 1 percent each. The major exporters are higher on a weaker yen. ( read original story ...)
Japanese shares at 3-1/2-month high as U.S. data boosts recovery hopes
Japanese stocks climbed to a fresh 3-1/2-month high on Monday after a surprise increase in U.S. employment gave investors further confidence of a swift global economic recovery from a ... ( read original story ...)
Japan Pharma Stock with 60% Gain This Year Vaults to Sony Size
There’s a new king in the world of Japanese pharma after hopes for a coronavirus treatment helped to turbocharge its shares. ( read original story ...)
Shares in cyber security group soar as digital attacks hit Japan
The explosive rise in the shares of Cyber Security Cloud have given a company with 45 employees a market capitalisation of around $800m. It listed on the Tokyo Stock Exchange’s Mothers board on March ... ( read original story ...)
Japan’s Economy Shrinks Less as Analysts Question Capex Figures
Japan’s economy shrank less than initially estimated in the first quarter, but analysts warn the latest revised figures may offer a misleading view of the economy’s health as the virus hit.The latest ... ( read original story ...)
Japan economy better than feared but still in recession
Japanese growth figures were better than initially feared in the first quarter, according to official data published on Monday, but the world's third-top economy was still mired deep in recession. ( read original story ...)
Japan’s GDP Shrinks Less as Economists Question Capex Data
Revised figures showed Japan’s economy contracted less than initially estimated in the first quarter based on a survey that may have overstated the strength of business investment amid the pandemic. ( read original story ...)
Japan Q1 GDP revised up to 2.2% annualised contraction
March, less than the initial estimate of a 3.4% contraction, revised data from the Cabinet Office showed Monday. On a quarter-on-quarter basis GDP shrank 0.6% compared with a 0.9% contraction in the ... ( read original story ...)
Goldman, Mizuho Expect Thaw in Japan Dealmaking to Gather Pace
Mergers are beginning to pick up in Japan after slumping to a 10-year low in April, and bankers expect the pace to accelerate as the coronavirus pandemic forces weaker companies to consolidate. ( read original story ...)
Bitcoin’s Short-Lived Spike; Russia Gets Tougher On Crypto
Some Russian crypto enthusiasts are hopeful that there is still room for interpretation in the law to allow for regulated security token offerings in the future. JPMorgan has come a long way since CEO ... ( read original story ...)
Japan, U.K. to Hold Trade Talks on Tuesday, Nikkei Says
Japanese Foreign Minister Toshimitsu Motegi and U.K. International Trade Secretary Liz Truss will on Tuesday discuss forming a new trade accord as Britain departs from the European Union, Nikkei ... ( read original story ...)
SEC targets crypto multi-level marketing scheme in new lawsuit
The Securities and Exchange Commission said Friday that it has filed charges against the alleged operators of a fraudulent cryptocurrency investment scheme.The post SEC targets crypto multi-level ... ( read original story ...)
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug
The biggest life sciences IPO of the year so far belongs to Legend Biotech. The cancer drug developer was able to raise $423.8 million after pricing its ... ( read original story ...)